197 results
Page 2 of 10
8-K
EX-99.1
2bpz30n5i
20 Sep 21
Soligenix to Advance Synthetic Hypericin Development in Psoriasis
4:01pm
424B5
zip9lgrnp8i2rphk3m
13 Aug 21
Prospectus supplement for primary offering
4:11pm
8-K
EX-10.1
n7i0ad4f75wztgyxd74
16 Dec 20
Soligenix Announces $20 Million Strategic Convertible Debt Financing Agreement with Pontifax Medison Debt Financing
4:31pm
8-K
EX-99.1
wicwsmf71p65qun3z1ti
20 Jul 20
Soligenix Issues Corporate Update – Highlights Important Catalysts for Second Half of 2020
7:00am
8-K
EX-99.1
jda83wfc6zjzpz0h 1w
30 Apr 20
Soligenix Announces Positive Phase 3 FLASH Study Demonstrates Increased Efficacy with Continued Treatment in Patients with Cutaneous T-Cell Lymphoma
7:05am
8-K
EX-99.1
5ze0 kbxkncr
19 Mar 20
Soligenix Announces Positive Top-line Results for its Pivotal Phase 3 FLASH Trial Evaluating SGX301 in Treatment of Cutaneous T-Cell Lymphoma
6:04am
8-K
EX-99.1
gtgbet wg9yq3
14 Jan 20
Soligenix – Advancing to Important Inflection Points
1:05pm
8-K
EX-99.1
s3ewkxd2yl 60zbj0a0
29 Aug 19
Final topline results remain on target for first half 2020
4:30pm